Retirement Planning Group (Kansas)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390K Buy
13,906
+1,100
+9% +$29.3K 0.01% 349
2025
Q4
$319K Sell
12,806
-959
-7% -$24.2K 0.01% 328
2025
Q3
$351K Buy
+13,765
New +$340K 0.01% 309
2025
Q2
Sell
-10,629
Closed -$269K 314
2025
Q1
$269K Sell
10,629
-1,794
-14% -$46.9K 0.01% 261
2024
Q4
$330K Buy
12,423
+208
+2% +$5.64K 0.02% 226
2024
Q3
$354K Buy
+12,215
New +$356K 0.02% 205
2023
Q1
Sell
-4,200
Closed -$215K 151
2022
Q4
$215K Buy
+4,200
New +$201K 0.02% 129
2022
Q3
Sell
-4,330
Closed -$227K 135
2022
Q2
$227K Sell
4,330
-434
-9% -$22.1K 0.03% 103
2022
Q1
$247K Buy
4,764
+557
+13% +$28.9K 0.03% 95
2021
Q4
$248K Buy
+4,207
New +$208K 0.02% 95

Other funds holding PFE

Retirement Planning Group (Kansas)'s PFE Position: Q1 2026 in Review

Retirement Planning Group (Kansas) increased its Pfizer (PFE) stake by 8.6% in Q1 2026, buying an estimated $29.3K and bringing the position to 13,906 shares worth $390K. The position accounts for 0.01% of the portfolio, ranked #349.

Retirement Planning Group (Kansas) first reported a position in PFE in Q4 2021 and has held it in 10 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Retirement Planning Group (Kansas) held 13,906 shares of Pfizer worth $390K as of Q1 2026.
  • Retirement Planning Group (Kansas) bought 1,100 Pfizer shares in Q1 2026, an estimated $29.3K.
  • Pfizer made up 0.01% of Retirement Planning Group (Kansas)'s portfolio in Q1 2026, its #349 holding.
  • Retirement Planning Group (Kansas) first reported a position in Pfizer in Q4 2021 and has held it in 10 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Retirement Planning Group (Kansas)'s 13F filing for Q1 2026, filed 4 May 2026.